Himalaya Nutravedics IPO Listing Details
| IPO Listing Date | September 29, 2026 |
| BSE Code | 544943 |
| ISIN Code | INE1OTR01013 |
| Offer Price | ₹100 to ₹106 |
| Face Value | ₹10 |
| Listing Price | ₹118 |
Details About Himalaya Nutravedics IPO
Himalaya Nutravedics received SEBI approval for an IPO of ₹26.50 crores via a fresh issue of ₹41.20 crores with a face value of ₹10 each. The price band was ₹100 to ₹106 per share.
In the Himalaya Nutravedics IPO, 2400 shares were offered in 2 lot sizes for the retail minimum and maximum categories.
The S-HNI category offered 3600 shares in 3 lot sizes.
The S-HNI category offered 8400 shares in 7 lot sizes.
The B-HNI Minimum category offered 9600 shares in 8 lot sizes.
To invest in the Himalaya Nutravedics IPO, each investor category has specific investment amounts:
- Retail Investors: Minimum and maximum investment of ₹2,54,400.
- S-HNI (Min): Minimum investment of ₹3,81,600.
- S-HNI (Max): Minimum investment of ₹8,90,400.
- B-HNI Minimum: Minimum investment of ₹10,17,600.
Himalaya Nutravedics IPO’s Subscription Duration
The opening date of the Himalaya Nutravedics IPO was September 22, 2026, and the closing date was September 24, 2026. The allotment date of the Himalaya Nutravedics IPO was September 25, 2026, and the investors will receive a refund on September 28, 2026. Himalaya Nutravedics is set to be listed on September 29, 2026.
Funds Deployment of This Company
- Working Capital Requirements
- Business Development and Digital Marketing Activities
- General corporate purposes
About Himalaya Nutravedics Company
Himalaya Nutravedics, founded in 2022, is one of the leading Ayurvedic and nutraceutical manufacturing firms involved in the formulation, manufacturing, and marketing of Ayurvedic and nutraceutical products. Its product portfolio includes Softgel Capsules, Tablets, Medicated Oils, Liquid Orals, Hardgel Capsules, and Protein Powders across therapeutic categories such as digestive health, immunity, metabolic health, and pain management.
The firm has expanded its portfolio across 17 states and one union territory in India. Moreover, its manufacturing facility is located in Hyderabad, Telangana, and holds WHO-GMP certifications.
